BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8590980)

  • 1. Competitive inhibition of coumarin 7-hydroxylation by pilocarpine and its interaction with mouse CYP 2A5 and human CYP 2A6.
    Kinonen T; Pasanen M; Gynther J; Poso A; Järvinen T; Alhava E; Juvonen RO
    Br J Pharmacol; 1995 Nov; 116(6):2625-30. PubMed ID: 8590980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ; Madan A; Parkinson A
    Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of CYP enzymes in mouse and human liver by pilocarpine.
    Kimonen T; Juvonen RO; Alhava E; Pasanen M
    Br J Pharmacol; 1995 Feb; 114(4):832-6. PubMed ID: 7773543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic characteristics of norcocaine N-hydroxylation in mouse and human liver microsomes: involvement of CYP enzymes.
    Pellinen P; Kulmala L; Konttila J; Auriola S; Pasanen M; Juvonen R
    Arch Toxicol; 2000 Nov; 74(9):511-20. PubMed ID: 11131030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic interactions of methoxsalen and coumarin in humans and mice.
    Mäenpää J; Juvonen R; Raunio H; Rautio A; Pelkonen O
    Biochem Pharmacol; 1994 Oct; 48(7):1363-9. PubMed ID: 7945434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
    Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
    Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes.
    Li Y; Li NY; Sellers EM
    Eur J Drug Metab Pharmacokinet; 1997; 22(4):295-304. PubMed ID: 9512924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pronounced differences in inhibition potency of lactone and non-lactone compounds for mouse and human coumarin 7-hydroxylases (CYP2A5 and CYP2A6).
    Juvonen RO; Gynther J; Pasanen M; Alhava E; Poso A
    Xenobiotica; 2000 Jan; 30(1):81-92. PubMed ID: 10659953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.
    Taavitsainen P; Juvonen R; Pelkonen O
    Drug Metab Dispos; 2001 Mar; 29(3):217-22. PubMed ID: 11181487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for metabolic activation of N'-nitrosonornicotine and N-nitrosobenzylmethylamine by a rat nasal coumarin hydroxylase.
    Patten CJ; Peterson LA; Murphy SE
    Drug Metab Dispos; 1998 Feb; 26(2):177-80. PubMed ID: 9456305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of comparative molecular field analysis modelling of naphthalene inhibition of human CYP2A6 and mouse CYP2A5 enzymes.
    Asikainen A; Tarhanen J; Poso A; Pasanen M; Alhava E; Juvonen RO
    Toxicol In Vitro; 2003 Aug; 17(4):449-55. PubMed ID: 12849728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
    Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
    Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of selective environmental substrates for human cytochrome P450 2A6: alkoxyethers, nicotine, coumarin, N-nitrosodiethylamine, and N-nitrosobenzylmethylamine.
    Le Gal A; Dréano Y; Lucas D; Berthou F
    Toxicol Lett; 2003 Sep; 144(1):77-91. PubMed ID: 12919726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver.
    Sai Y; Yang TJ; Krausz KW; Gonzalez FJ; Gelboin HV
    Pharmacogenetics; 1999 Apr; 9(2):229-37. PubMed ID: 10376770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and interspecies comparisons.
    Pelkonen O; Sotaniemi EA; Ahokas JT
    Br J Clin Pharmacol; 1985 Jan; 19(1):59-66. PubMed ID: 3978021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human and mouse liver coumarin 7-hydroxylases do not metabolize warfarin in vitro.
    Honkakoski P; Arvela P; Juvonen R; Lang MA; Kairaluoma M; Pelkonen O
    Br J Clin Pharmacol; 1992 Mar; 33(3):313-7. PubMed ID: 1576054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of aflatoxin B1 with cytochrome P450 2A5 and its mutants: correlation with metabolic activation and toxicity.
    Pelkonen P; Lang MA; Negishi M; Wild CP; Juvonen RO
    Chem Res Toxicol; 1997 Jan; 10(1):85-90. PubMed ID: 9074807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel sensitive high-performance liquid chromatographic method for assay of coumarin 7-hydroxylation.
    Soucek P
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 734(1):23-9. PubMed ID: 10574186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.
    Nakajima M; Yamamoto T; Nunoya K; Yokoi T; Nagashima K; Inoue K; Funae Y; Shimada N; Kamataki T; Kuroiwa Y
    J Pharmacol Exp Ther; 1996 May; 277(2):1010-5. PubMed ID: 8627511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
    Heyn H; White RB; Stevens JC
    Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.